Black Women Underrepresented in Immunotherapy Trials
“Racial inequity in healthcare delivery and outcomes in the United States is well-documented, and...
Breaking Oncology / Hematology
Exploring Healthcare Super-Utilization in Gynecologic Oncology
Unplanned acute care continues to be a major contributor to growing healthcare costs in the United...
Advanced Ovarian Cancer: Identifying Opportunities for Prehabilitation
Patients with epithelial ovarian cancer most commonly present when their disease has reached an...
FDA Approves Amivantamab for NSCLC with EGFR Mutations
The first targeted treatment for this population requires Dx with an FDA-approved test The FDA granted intravenous amivantamab-vmjw (Rybrevant) accelerated approval for adult patients with non-small cell lung cancer with...
FDA OKs Pegcetacoplan for Paroxysmal Nocturnal Hemoglobinuria
Patients with rare blood disease can access drug through REMS The FDA approved subcutaneous pegcetacoplan (Empaveli) for adults with paroxysmal nocturnal hemoglobinuria (PNH), a rare and serious blood disease that affects 1-1.5...
Breast Cancer: CT-Planning Scans Can Inform Cardio-Onco Strategy
CAC score may guide breast ca Tx and CVD prevention The risk of cardiovascular disease, particularly coronary artery disease, among breast cancer survivors is well-known, but a study from Dutch researchers suggests that CT scans...
CME/CE: Examining the Risk of VTE in Ovarian Cancer
This course discusses a meta-analysis of the most reported and discussed risk factors for venous...
FDA Advisors Consider Fate of Antibodies Granted Conditional Approval
So-called ’dangling’ approvals get second look Over three days of meetings beginning April 27, the FDA’s Oncologic Drugs Advisory Committee (ODAC) will consider a pivotal question: did the FDA grant...
FDA OKs Nivolumab as First-line Tx for Gastric Cancers
First immunotherapy approved as first-line Tx for gastric, gastroesophageal, and esophageal cancer The FDA approved nivolumab (OPDIVO) in combination with chemotherapy as a first-line treatment for advanced or metastatic gastric...
FDA Approves AI Device to Help ID Colon Cancer
Device highlights potential lesions during colonoscopy The FDA approved an artificial intelligence (AI) device to help clinicians identify potential signs of colon cancer during a colonoscopy.The GI Genius uses an AI algorithm...
Universal Screening for Lynch Syndrome in Patients With Uterine Cancer
“Lynch syndrome (LS) is the most common hereditary cause of uterine cancer,” explains Daniel...
Expanding Lynch Syndrome Screening to Include Ovarian Cancer
Although the benefits of universal screening for colorectal cancer (CRC) and endometrial cancer...
